Can a texting buddy help new moms battling opioid addiction?
NCT ID NCT06969261
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is adapting a friendly text-message chatbot called Penny to support pregnant and postpartum women who are recovering from opioid use disorder. The chatbot sends helpful messages and allows two-way conversations to reduce loneliness and keep women engaged in their care. Researchers will test it with 20 women to see if it's acceptable, easy to use, and satisfying.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Penny COPILOT chatbot (behavioral intervention via SMS)
What this could lead to
If successful, this chatbot could offer a low-cost, scalable way to support perinatal women with opioid use disorder, reducing loneliness and relapse risk.
What could go wrong
This is a very small pilot study (20 participants) focused on feasibility, not effectiveness. The chatbot may not work for everyone, and results may not apply to broader populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital of the University of Pennsylvania (HUP)
RECRUITINGPhiladelphia, Pennsylvania, 19072, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Pennsylvania
NOT_YET_RECRUITINGPhiladelphia, Pennsylvania, 19104-3309, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••